Expanded Access and Compassionate Use in UK Clinical Trials
Expanded Access and Compassionate Use in UK Clinical Trials Expanded Access and Compassionate Use in the United Kingdom: Regulatory and Practical Insights Expanded access and compassionate use programmes provide patients with serious or life-threatening conditions an opportunity to receive investigational medicines outside of standard clinical trials. In the United Kingdom (UK), these mechanisms play a…
Read More “Expanded Access and Compassionate Use in UK Clinical Trials” »